| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2011/02/24 | 20 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 20 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 20 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06 : 38 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/23 | 07 : 06 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 09 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 07 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06 : 02 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/16 | 07 : 03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/16 | 01 : 57 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/15 | 09 : 07 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/15 | 03 : 52 | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/11 | 04 : 36 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 20 : 08 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08 : 04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/08 | 23 : 34 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |